
Papersens launches non-invasive diagnostic tests using nanotechnology
The story in brief
Mangaluru-based biotech startup Papersens is developing non-invasive diagnostic tests using gold nanoparticles and graphene quantum dots to detect diseases through urine, sweat, and saliva. Targeting Tier-2 and 3 towns with limited lab infrastructure, the company has completed trials with 250-300 patients, secured a manufacturing license, and plans a pan-India clinical study before commercial launch.